3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Keratosis, Actinic
25
Uterine Cervical Dysplasia
13
Melanoma
10
Carcinoma, Basal Cell
10
Glioma
6
Glioblastoma
6
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Neoplasm Metastasis
4
Condylomata Acuminata
4
Precancerous Conditions
3
Papillomavirus Infections
3
Keratosis
3
Hutchinson's Melanotic Freckle
3
Vulvar Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasms
2
Hemangioma, Capillary
2
HIV Infections
2
Ependymoma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Warts
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Interventions
Radiotherapy
11
Brachytherapy
7
fludarabine
5
Radiation
5
Cyclophosphamide
5
aldesleukin
4
Magnetic Resonance Spectroscopy
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Cisplatin
4
fludarabine phosphate
3
durvalumab
3
Vaccines, Synthetic
3
Radiosurgery
3
Papillomavirus Vaccines
3
Paclitaxel
3
Methods
3
Early Intervention, Educational
3
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
3
tremelimumab
2
entinostat
2
aflibercept
2
Vaccines
2
Trastuzumab
2
Topotecan
2
Therapeutics
2
Platinum
2
Palliative Care
2
Nivolumab
2
Immunoglobulin G
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Vaginal Neoplasms
×
Imiquimod
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled